| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3946389 | Gynecologic Oncology | 2007 | 5 Pages |
Abstract
Survival among the minimal and low risk groups is preserved in spite of less radical surgery. 5-year survival rate for intermediate and high risk patients also appears to be improved. This is likely a result of advancement in adjuvant chemo-radiation and a younger patient population that presents with less advanced disease.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Lisa M. Landrum, Grainger S. Lanneau, Valerie J. Skaggs, Natalie Gould, Joan L. Walker, D. Scott McMeekin, Michael A. Gold,